《全日速報》恆指升291點; 恆生科技指數升75點 平安升逾3% 巨子生物、中交、中國鐵建創新高 成交暢旺
恆指全日收19,539點,升291點或1.5%。恆生科技指數報3,866點,升75點或2.0%。國指升120點或1.9%,報6,559點。大市成交額1,080.56億元。
活躍重磅股表現:
平安(02318.HK) 收52.25元,上升3.1%;
港交所(00388.HK) 收330.6元,上升2.9%;
建行(00939.HK) 收5.05元,上升2.6%;
阿里巴巴(09988.HK) 收82.05元,上升2.6%;
美團(03690.HK) 收126.7元,上升1%;
騰訊(00700.HK) 收344.6元,上升0.9%;
友邦(01299.HK) 收80.5元,下跌0.3%;
異動恆指及國指成份股:
東方海外(00316.HK) 收132.9元,上升8.8%;
阿里健康(00241.HK) 收5.67元,上升5.6%;
碧桂園服務(06098.HK) 收12.9元,上升4.5%;
龍湖(00960.HK) 收21元,上升4.5%;
京東健康(06618.HK) 收55.55元,上升4%;
網易(09999.HK) 收134元,上升3.7%;
百度集團-SW(09888.HK) 收133.6元,上升3.6%;
國壽(02628.HK) 收13.08元,上升3.5%;
招行(03968.HK) 收40.65元,上升3.2%;
郵儲銀行(01658.HK) 收4.99元,上升3.1%;
信義玻璃(00868.HK) 收14.08元,上升3.1%;
翰森製藥(03692.HK) 收14.2元,上升3%;
聯通(00762.HK) 收5.8元,下跌3%;
異動綜合中小型股:
叮噹健康(09886.HK) 收4.79元,下跌34.8%;
博安生物(06955.HK) 收24.55元,上升25.9%;
金山雲(03896.HK) 收2.7元,上升21.1%;
飛天雲動(06610.HK) 收3.59元,下跌16.1%;
龍光集團(03380.HK) 收0.94元,上升14.6%;
洪九果品(06689.HK) 收32.15元,上升14.4%;
FIT HON TENG(06088.HK) 收1.82元,下跌13.7%;
艾美疫苗(06660.HK) 收41.2元,下跌11.3%;
諾輝健康(06606.HK) 收33.45元,上升10.6%;
平安好醫生(01833.HK) 收20.15元,上升10.4%;
巨子生物(02367.HK) 收53.85元,上升9.1%,創新高;
中交(01800.HK) 收5元,上升5.7%,創新高;
中國鐵建(01186.HK) 收5.74元,上升5.5%,創新高;
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.